Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Drug Evaluation × Myeloid × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 2 Breast 2 Myeloid 1 Gastrointestinal 1 CNS 1

Conditions

Thrombocythemia, Essential 1 Polycythemia Vera 1

Interventions

Cyclophosphamide 128 fludarabine phosphate 115 Busulfan 94 fludarabine 84 Mycophenolic Acid 79 Tacrolimus 78 Whole-Body Irradiation 71 Peripheral Blood Stem Cell Transplantation 66 Imatinib Mesylate 63 Azacitidine 62 Antilymphocyte Serum 59 Cyclosporine 57 Cytarabine 55 Melphalan 54 Methotrexate 49 Filgrastim 43 Decitabine 38 thymoglobulin 33 Granulocyte Colony-Stimulating Factor 33 Thiotepa 32 Stem Cell Transplantation 30 Radiotherapy 28 Dasatinib 28 nilotinib 26 ruxolitinib 25 Cord Blood Stem Cell Transplantation 25 venetoclax 22 Methylprednisolone 22 Specimen Handling 20 Sirolimus 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02577926 2025-06-10

Ruxo-BEAT

RWTH Aachen University

Phase 2 Active not recruiting

Polycythemia Vera, Thrombocythemia, Essential

Data powered by HemOnc (CC BY 4.0) Colophon ⚡